DK1320383T3 - Fotosensibilatorer - Google Patents

Fotosensibilatorer

Info

Publication number
DK1320383T3
DK1320383T3 DK01967542T DK01967542T DK1320383T3 DK 1320383 T3 DK1320383 T3 DK 1320383T3 DK 01967542 T DK01967542 T DK 01967542T DK 01967542 T DK01967542 T DK 01967542T DK 1320383 T3 DK1320383 T3 DK 1320383T3
Authority
DK
Denmark
Prior art keywords
pdt
compound
conditions
functionality
compounds
Prior art date
Application number
DK01967542T
Other languages
Danish (da)
English (en)
Inventor
Stanley Beames Brown
Andrea Lucille Bell
John Griffiths
Jack Schofield
Original Assignee
Photopharmica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photopharmica Ltd filed Critical Photopharmica Ltd
Application granted granted Critical
Publication of DK1320383T3 publication Critical patent/DK1320383T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Glass Compositions (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Saccharide Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Weting (AREA)
DK01967542T 2000-09-23 2001-09-21 Fotosensibilatorer DK1320383T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023367.6A GB0023367D0 (en) 2000-09-23 2000-09-23 Photosensitisers
PCT/GB2001/004224 WO2002024226A2 (en) 2000-09-23 2001-09-21 Photosensitisers

Publications (1)

Publication Number Publication Date
DK1320383T3 true DK1320383T3 (da) 2007-09-24

Family

ID=9899999

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01967542T DK1320383T3 (da) 2000-09-23 2001-09-21 Fotosensibilatorer

Country Status (15)

Country Link
US (1) US7276494B2 (es)
EP (1) EP1320383B1 (es)
JP (1) JP2004509151A (es)
AT (1) ATE364397T1 (es)
AU (2) AU8791501A (es)
CA (1) CA2423252C (es)
CY (1) CY1107735T1 (es)
DE (1) DE60128932T2 (es)
DK (1) DK1320383T3 (es)
ES (1) ES2287154T3 (es)
GB (1) GB0023367D0 (es)
NO (1) NO20031310L (es)
NZ (1) NZ525420A (es)
PT (1) PT1320383E (es)
WO (1) WO2002024226A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500227A (ja) * 2003-05-29 2007-01-11 ミトス・ファーマシューティカルズ・インコーポレーテッド 光増感剤及び音増感剤と関連してのニトロキシドの使用方法
US7101997B2 (en) * 2004-10-07 2006-09-05 Honeywell International Inc. Method for producing phenothiazinium compounds
EP2368597A1 (en) * 2006-04-28 2011-09-28 Ondine International Holdings Ltd. Photodisinfection devices and methods
US20080139991A1 (en) * 2006-12-08 2008-06-12 Ondine International, Ltd. Method of wound disinfecting and tissue welding
US20080269205A1 (en) * 2007-04-27 2008-10-30 Ondine International, Ltd. Methods to prevent vertical transmission of infectious diseases
US20090035725A1 (en) * 2007-08-02 2009-02-05 Ondine International, Ltd. Photodisinfection of oral cavity
KR20100138922A (ko) * 2008-02-13 2010-12-31 안드레아스 로즈 방사광 출력 패턴을 제공하는 광 전달장치
KR101631335B1 (ko) * 2008-08-01 2016-06-16 온딘 인터내셔널 리미티드. Mrsa 치료용 조성물 및 방법
WO2010036617A1 (en) * 2008-09-23 2010-04-01 Ondine International Holdings Ltd. Portable photodynamic disinfection light delivery device for catheter disinfection
SG185094A1 (en) 2010-04-30 2012-12-28 Prostetta Antiviral Inc Antiviral compounds
EP2699241B1 (en) 2011-04-20 2016-07-27 Prosetta Antiviral Inc. Antiviral compounds
CN106138019A (zh) * 2015-03-25 2016-11-23 中国科学院大连化学物理研究所 Gpr35受体激动剂及其应用
US20240245774A1 (en) 2023-01-25 2024-07-25 Ondine International Ag Composition and a photodynamic therapeutic method to shorten infectivity period and to induce sustained humoral and cellular t-cell responses against a targeted antigen in infected individuals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59179569A (ja) * 1983-03-29 1984-10-12 Canon Inc 記録液
DE3727896A1 (de) 1987-08-21 1989-03-02 Degussa Verfahren zur herstellung von salzen des n-acetylcysteins oder -homocysteins
JPH079477B2 (ja) 1987-09-09 1995-02-01 株式会社日立製作所 原子力発電プラントの放射能低減法及び原子力発電プラント
JPS6470096A (en) 1987-09-10 1989-03-15 Brother Ind Ltd Pattern forming apparatus in zigzag sewing machine
JP2567257B2 (ja) * 1987-09-30 1996-12-25 日本化薬株式会社 カラーフィルター
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
JPH0749545B2 (ja) * 1988-01-26 1995-05-31 株式会社リコー 水性インク組成物
JP2534892B2 (ja) * 1988-06-22 1996-09-18 日本化薬株式会社 カラ―フィルタ―
US5162509A (en) * 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
JPH04218001A (ja) * 1990-03-30 1992-08-07 Nippon Kayaku Co Ltd カラーフィルター
JPH04322425A (ja) 1991-04-23 1992-11-12 Toshiba Corp 銅膜のエッチング方法
JP3430512B2 (ja) * 1994-04-25 2003-07-28 セイコーエプソン株式会社 水性インク組成物およびそれを用いた記録方法
JPH0829777A (ja) * 1994-07-19 1996-02-02 Canon Inc カラーフィルタ、その製造方法、及びカラーフィルタを備えた液晶パネル
JP3874376B2 (ja) * 1996-04-26 2007-01-31 日本化薬株式会社 カラーフィルタの製造方法
DE19634354A1 (de) * 1996-08-26 1998-03-05 Clariant Gmbh Wasserlösliche Kupferphtalocyanin-Farbstoffe, ihre Herstellung und Verwendung
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
EP1091742A4 (en) * 1997-02-14 2007-05-30 Miravant Pharm Inc PHOTOSENSITIVE INDIUM, FOR TPD

Also Published As

Publication number Publication date
WO2002024226A3 (en) 2002-08-01
PT1320383E (pt) 2007-08-28
GB0023367D0 (en) 2000-11-08
CA2423252C (en) 2009-01-20
NZ525420A (en) 2003-09-26
CY1107735T1 (el) 2013-04-18
DE60128932T2 (de) 2008-02-21
NO20031310L (no) 2003-05-20
WO2002024226A2 (en) 2002-03-28
WO2002024226A9 (en) 2003-05-08
EP1320383B1 (en) 2007-06-13
AU8791501A (en) 2002-04-02
US7276494B2 (en) 2007-10-02
CA2423252A1 (en) 2002-03-28
WO2002024226A8 (en) 2002-11-21
ES2287154T3 (es) 2007-12-16
NO20031310D0 (no) 2003-03-21
DE60128932D1 (de) 2007-07-26
US20030180224A1 (en) 2003-09-25
JP2004509151A (ja) 2004-03-25
AU2001287915B2 (en) 2005-11-24
EP1320383A2 (en) 2003-06-25
ATE364397T1 (de) 2007-07-15

Similar Documents

Publication Publication Date Title
CY1107735T1 (el) Φωτο-ευαισθητοποιητες
Kübler Photodynamic therapy
WO2003032901A3 (en) Pathological tissue detection and treatment employing targeted benzoindole optical agents
Kawczyk-Krupka et al. Photodynamic therapy in treatment of cutaneous and choroidal melanoma
Abdel-kader The journey of PDT throughout history: PDT from Pharos to present
ES2643666T3 (es) Composición para el tratamiento fotodinámico de la piel
CA2448303A1 (en) Biologically active methylene blue derivatives
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
WO2003032900A3 (en) Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
JP2017519026A (ja) ハロゲンを含む生体光組成物およびその使用
Dtlkes et al. Treatment of head and neck cancer with photodynamic therapy: results after one year
WO2001024825A3 (en) Significance of dosimetry in photodynamic therapy of injured arteries
EP2292226A3 (en) The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
WO2003032902A3 (en) Tumor targeted photodiagnostic-phototherapeutic agents
WO2005048944A3 (en) Activatable photodynamic therapy agents
Frazier Photodynamic therapy in dermatology.
Fabbrocini et al. Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results
Allison et al. Photofrin® photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question
Rho et al. Miniature wireless LED-device for photodynamic-induced cell pyroptosis
Poh-Fitzpatrick [43] Porphyrias: Photosensitivity and phototherapy
Al Timimi Cancer treatment based on the selective accumulation of a photosensitiser and laser light irradiation: A review
Jain et al. Applications of photosensitizer in therapy
Jain et al. A Review on Future Prospects of Photosensitizers in Photodynamic Therapy
RU2566201C1 (ru) Способ лечения витилиго
Kaleli et al. In-Vivo Photodynamic Therapy Studies in Cancer